Clinical Trial Update: Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial evaluating the safety, tolerability, and efficacy of PF-04360365 in adults with probable cerebral amyloid angiopathy, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Amyloid Angiopathy

Drugs mentioned

• PF-04360365

Snippet

Sponsor: Pfizer | Conditions: Cerebral Amyloid Angiopathy | Phase 2 | Status: COMPLETED | Results posted: 2016-11-03